Tumour-initiating cells (TICs) are responsible for metastatic dissemination and clinical relapse in a variety of cancers 1, 2 . Analogies between TICs and normal tissue stem cells have led to the proposal that activation of the normal stem-cell program within a tissue serves as the major mechanism for generating TICs [3] [4] [5] [6] [7] . Supporting this notion, we and others previously established that the Slug epithelial-to-mesenchymal transition-inducing transcription factor (EMT-TF), a member of the Snail family, serves as a master regulator of the gland-reconstituting activity of normal mammary stem cells, and that forced expression of Slug in collaboration with Sox9 in breast cancer cells can efficiently induce entrance into the TIC state 8 . However, these earlier studies focused on xenograft models with cultured cell lines and involved ectopic expression of EMT-TFs, often at non-physiological levels. Using genetically engineered knock-in reporter mouse lines, here we show that normal gland-reconstituting mammary stem cells [9] [10] [11] residing in the basal layer of the mammary epithelium and breast TICs originating in the luminal layer exploit the paralogous EMT-TFs Slug and Snail, respectively, which induce distinct EMT programs. Broadly, our findings suggest that the seemingly similar stem-cell programs operating in TICs and normal stem cells of the corresponding normal tissue are likely to differ significantly in their details.
To define the functions of endogenously encoded, physiologically regulated Snail family EMT-TFs in breast cancer pathogenesis in vivo, we generated knock-in IRES (internal ribosomal entry site)-YFP (yellow fluorescent protein) reporters for Slug (also called Snai2) and Snail (also called Snai1) ( Fig. 1a, b ). These knock-in reporters faithfully reflected the expression of the endogenous genes (Extended Data Fig. 1a, b) , and enabled the isolation of Slug 1 or Snail 1 cells by fluorescence-activated cell sorting (FACS) (Extended Data Fig. 6e -h).
Using these reporters, we found that Slug was expressed at higher levels in the normal mammary stem cell (MaSC)-enriched basal mammary epithelial cells (MECs) compared to the stromal fibroblasts surrounding the mammary ducts. In contrast, the EMT-TFs Snail, Twist and Zeb1 were expressed in stromal fibroblasts but not in either basal or luminal MECs ( Fig. 1c -e, g and Extended Data Fig. 1c-f ). In addition to the differential expression of EMT-TFs, the MaSC-enriched basal MECs displayed intermediate expression levels of both epithelial and mesenchymal markers (Fig. 1f , g and Extended Data Fig. 1g ). Hence, Slug expression in the normal basal MECs was associated with only a partial conversion to the mesenchymal state.
Given the differential expression patterns of Slug and Snail, we undertook to analyse their expression during tumour development using the MMTV-PyMT transgenic model of mammary tumour formation, which mirrors the multi-step progression of human breast cancers beginning from hyperplastic lesions to high-grade carcinomas that spontaneously metastasize to the lungs 12 . In the initially formed hyperplastic lesions, we noted a marked reduction of the relative frequency of Slug-YFP 1 cells compared to normal glands, contrary to the hypothesis that activation of the Slug EMT-TF might be the preferred mechanism to generate TICs. These Slug-YFP 1 cells were cytokera-tin14 1 (CK14) ( Fig. 2a and Extended Data Fig. 2f ), indicating that Slug expression was still confined to cells of the basal lineage, as was the case within the normal ducts. In these early-stage lesions, we detected for the first time Snail-YFP expression in a small fraction of the neoplastic cells displaying CK8 1 Slug 2 Zeb1 2 luminal characteristics ( Fig. 2a, b and Extended Data Fig. 2a-c) .
As these early-stage tumours progressed to high-grade carcinomas, the Slug 1 cells remained largely confined to the basal sectors of each epithelial island, whereas the Snail 1 cancer cells were sometimes fully detached from the epithelial islands and exhibited an elongated mesenchymal morphology ( Fig. 2c ). We found that virtually all Snail-YFP 1 tumour cells had lost E-cadherin expression and activated expression of the Zeb1 EMT-TF; in contrast, most Slug-YFP 1 tumour cells retained junctional E-cadherin and lacked Zeb1 expression Fig. 2d ). Therefore, Snail rather than Slug is associated with more complete expression of mesenchymal traits in mammary tumours.
Notably, as tumours progressed, we noted that the Snail-YFP 1 cells gradually acquired basal CK14 expression and lost luminal CK8 expression ( Fig. 2e and Extended Data Fig. 2c , e), consistent with the proposal that in human breast carcinomas, aggressive cancer cells exhibiting basal features can arise from luminal precursors [13] [14] [15] [16] [17] . To compare the activation of Slug and Snail during such luminal-basal transitions, we used an organoid culture system in which CK14 is spontaneously activated as the tumour cells invade into a type I collagen gel 13 . We dissociated adenocarcinomas into tumour organoids as previously described 13 . These freshly isolated tumour organoids were almost exclusively of luminal phenotype (CK8 1 CK14 2 ) and lacked both Slug-YFP and Snail-YFP expression (Extended Data Fig. 3a ). After 48 h in culture, CK14 expression was induced in tumour cells at the invasive fronts of these organoids. Strikingly, this induction was tightly associated with Snail-YFP but not Slug-YFP activation ( Fig. 2f and Extended Data Fig. 3b, c) .
Taken together, these analyses indicate that the EMT-TF that is activated in the MMTV-PyMT mammary tumours (that is, Snail) is distinct from the one expressed in the normal gland-reconstituting MaSCs (that is, Slug), and that expression of Snail rather than its paralogue Slug is associated with potent EMT activation and eventual acquisition of basal features (Extended Data Fig. 3d ).
To extend and generalize these observations further, we compared Slug, Snail and Zeb1 expression patterns in the MMTV-Neu 18 and BRCA1/p53-minus 19 transgenic models of breast cancer development. Snail activation had previously been associated with recurrence and metastasis formation in the MMTV-Neu model 20, 21 . Consistently, we found that Snail and Zeb1 are activated in ,1-2% of tumour cells within MMTV-Neu tumours that are associated with metastatic disease, which contained no evidence of Slug expression (Extended Data Fig. 4a -c). The BRCA1/p53-minus tumours were highly heterogeneous and harboured areas with epithelial and glandular phenotypes as well as areas with mesenchymal and invasive phenotypes (Extended Data Fig. 4d , g). We found that Slug was predominantly expressed by cells occupying the basal sectors of the gland-like structures (echoing its expression in normal ducts), whereas Snail and Zeb1 were predominantly expressed in the invasive cells (Extended Data Fig. 4d-h ). Hence, differential expression of Slug and Snail appears to be a conserved feature of mammary tumours driven by diverse oncogenic signals.
We were curious whether differential expression of SLUG and SNAIL was also observable in human breast cancer cells, and therefore surveyed SLUG versus SNAIL expression in human breast cancer cell lines. Mirroring our observations in the mouse models, SNAIL but not SLUG was expressed in luminal breast cancer cells, and the two EMT-TFs were expressed in distinct (but occasionally overlapping) populations in basal breast cancer cells (Extended Data Fig. 5a, b ). In addition to these genetically unrelated breast cancer cell lines, we compared SLUG and SNAIL expression in an MCF10A-based model of breast cancer progression 22 . This model consists of the immortalized, non-tumorigenic MCF10A human MECs, MCF10A cells transformed with an H-RAS oncogene (MCF10A-Ras), and a cell line established from an MCF10A-Ras cell-derived carcinoma (MCF10A-Ras-C). We found that SLUG was expressed in MCF10A cells, but was downregulated in MCF10A-Ras-C cells. In contrast, SNAIL was absent in MCF10A cells, but underwent activation in MCF10A-Ras cells and further upregulation in MCF10A-Ras-C cells (Extended Data Fig. 5c, d ).
To summarize, these results indicated that the differential expression of Slug and Snail is a common feature of mammary tumours despite their different subtypes, genetic backgrounds and oncogenic drivers. Although Snail is absent in normal MECs, it often becomes activated during breast cancer progression. Indeed, SNAIL expression was detected in ,80% microdissected human invasive ductal carcinomas 23 .
Our observations raised the question of whether the Slug 1 , Snail 1 , or yet other cell subpopulations within mammary tumours were enriched in TICs. To address this issue, we developed a system that allowed us to isolate these various subpopulations. Thus, we FACSpurified premalignant EpCAM 1 MECs from 4-5-week-old Slug YFP/1 ; MMTV-PyMT;RFP (red fluorescent protein) or Snail YFP/1 ;MMTV-PyMT;RFP animals, and thereafter implanted these cells into cleared mammary fat pads of hosts that lacked these transgenes (Fig. 3a) . The implanted premalignant MECs first grew as rudimentary ductal structures and then progressed over 6-7 months to form high-grade carcinomas that metastasized to the lungs (Extended Data Fig. 6a, b ).
We FACS-resolved the RFP 1 carcinoma cells based on the expression levels of the YFP (Slug or Snail) reporter and the EpCAM epithelial marker. In the high-grade carcinomas and corresponding pulmonary metastases, EpCAM expression was downregulated in 4-12% of the carcinoma cells. These EpCAM low cells had low Slug-YFP expression ( Fig. 3b and Extended Data Fig. 5c ) but high Snail-YFP expression ( Fig. 3c and Extended Data Fig. 5d ). In contrast, the EpCAM high populations were Snail-YFP low (Fig. 3c ), and were composed of Slug-YFP low EpCAM high and Slug-YFP high EpCAM high subpopulations (Fig. 3b ). Hence, EpCAM expression was inversely correlated only with Snail expression.
Using quantitative reverse transcription PCR (qRT-PCR) analyses, we confirmed that Snail expression was highest in the EpCAM low subpopulations, whereas Slug was enriched in EpCAM high subpopulations ( Fig. 3d, e ). As expected, strong induction of mesenchymal markers and suppression of E-cadherin were only seen in the EpCAM low subpopulations ( Fig. 3d, e ). Using cell lines derived from Slug YFP/1 ;MMTV-PyMT and Snail YFP/1 ;MMTV-PyMT tumours, we also observed the segregation of Slug and Snail expression at the protein level and associated Snail but not Slug expression with strong induction of a mesenchymal phenotype (Extended Data Fig. 6e-h) .
Together, these observations demonstrated our ability to resolve and isolate distinct tumour cell subpopulations with high levels of either Slug (Slug high ) or Snail (Snail high ) from the same primary tumours (Extended Data Fig. 7a ), allowing us, in turn, to directly compare their respective tumour-initiating activities. To this end, we FACS-purified these subpopulations (Extended Data Fig. 6e -h) and implanted each at limiting dilutions to score tumour formation. Overall, Snail high subpopulations exhibited more than two orders of magnitude higher proportions of TICs than did the other subpopulations. In contrast, the Slug-YFP high cells were as deficient in tumour-initiating ability as the Slug-YFP low EpCAM high cells (Extended Data Fig. 7b , c). Hence, Snail but not Slug was tightly associated with a TIC phenotype.
To compare the TIC activities and metastatic powers of these tumour cell subpopulations coexisting in the same primary tumours in vivo, we FACS-purified each subpopulation from highly metastatic carcinomas generated by Slug YFP ;MMTV-PyMT;RFP cells and introduced them via the tail vein to gauge their respective abilities to seed pulmonary metastases. Notably, the Snail high cells consistently gave rise to far more metastatic outgrowths relative to the EpCAM high subpopulations. In particular, 40,000 Snail high cells from a highly metastatic primary tumour (Extended Data Fig. 8a ) seeded on average ,90 large metastases in each animal. In contrast, 40,000 cells of the Slug high and Slug-YFP low EpCAM high subpopulations from the same tumour seeded an average of only 3.6 and 2.2 metastases per animal, respectively ( Fig. 3f and Extended Data Fig. 8b ). The Snail high cells were also far more metastatic than the other two populations when implanted subcutaneously ( Fig. 3g and Extended Data Fig. 8e-g) . Interestingly, the metastatic outgrowths formed by the Snail high cells harboured gland-like structures composed of both Slug 1 and Slug 2 cells (Extended Data Fig. 8c, d) . Hence, the Snail high cells that seeded metastases were capable of differentiating within these outgrowths, thereby regenerating the complex cellular hierarchy present in the original primary tumours. These data also revealed that the TICs did not derive from basal MaSC-like cells (that is, the Slug high cells) but instead arose in a different cell population.
We were curious whether correlates of these distinct behaviours of SLUG and SNAIL could be found in human clinical data sets, and therefore examined the prognostic powers of SLUG or SNAIL (ref. 24) . Across various patient populations, we found that only elevated expression of SNAIL consistently associated with poor survival (Extended Data Fig. 9a ).
These results strongly argue for divergent roles of Slug and Snail, and predicted that shutdown of Snail could selectively eliminate breast TICs. To test this notion, we knocked down either Slug or Snail in advanced MMTV-PyMT carcinoma-derived pBl.3G cells and MDA-MB-231 human breast cancer cells (Extended Data Fig. 9b , c). Strikingly, Snail knockdown but not Slug knockdown induced mesenchymal-to-epithelial transition (MET), leading to loss of Zeb1 and reactivation of E-cadherin ( Fig. 4a, b ). When these cells were injected orthotopically into mammary fat pads, Snail but not Slug knockdown attenuated primary tumour growth and strongly suppressed their metastatic spreading ( Fig. 4c-e ). Similarly, across a panel of human breast cancer cell lines, we found that SNAIL knockdown significantly suppressed tumour initiation in most of them, while SLUG knockdown failed to do so (Extended Data Fig. 9d-f ). In contrast to the responses of breast cancer cells, the organoid-forming and gland-reconstituting activities of normal murine MaSCs were markedly affected by Slug knockdown but not by Snail knockdown (Fig. 4f and Extended Data Fig. 9g ).
Given the distinct functions exerted by Slug and Snail, we analysed the transcription programs controlled by these paralogous EMT-TFs using ChIP-seq. We focused on two MMTV-PyMT tumour cell lines that differed in Slug and Snail expression and tumorigenic potential (Extended Data Fig. 10a, b ). We recovered similar numbers of chromatin regions that were enriched for either Slug or Snail binding ( Fig. 5a ). Across the genome, Slug-and Snail-binding sites displayed similar fold enrichments and were both enriched for the known Snail family recognition CANNTG E-box motif 25 (Extended Data Fig. 10c, d ). We found that Snail occupied 10,129 promoters, far more than that occupied by Slug (2,475 promoters) ( Fig. 5b) . Interestingly, the promoters of genes encoding key mesenchymal markers were only bound by Snail but not by Slug (Extended Data Fig. 10e ). Gene-set enrichment analyses (GSEA) confirmed that Snail-bound but not Slug-bound genes were significantly enriched for EMT-related signatures (Fig. 5c ). In particular, Snail, but not Slug, occupied the promoter of Zeb1 (Fig. 5d 
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TICs under a variety of settings [26] [27] [28] . The binding of Snail appears to activate Zeb1 expression in mammary tumour cells, because knockdown of Snail led to downregulation of Zeb1 (Fig. 4a, c) , and ectopic expression of SNAIL in human MECs induced ZEB1 expression (Extended Data Fig. 10f ). Indeed, Snail had been reported to activate Zeb1 expression in non-mammary types of epithelial cells 29, 30 .
To investigate the possible differential abilities of SLUG and SNAIL in controlling ZEB1 expression in human breast cancer cells, we used ChIP-qPCR to examine SLUG and SNAIL binding at the ZEB1 promoter in MDA-MB-231 cells, which co-express SLUG and SNAIL.
Notably, although both SLUG and SNAIL appeared to occupy the ZEB1 promoter in these cells, SLUG binding (but not SLUG expression) was diminished in SNAIL knockdown cells ( Fig. 5e-g ). Since the knockdown of SNAIL, but not SLUG, resulted in downregulation of ZEB1 in MDA-MB-231 cells (Fig. 4c ) and the binding of SLUG to the ZEB1 promoter is dependent on SNAIL expression, we concluded that ZEB1 expression was controlled by SNAIL but not SLUG in MDA-MB-231 cells as well.
Our data underscore profound differences in the transcriptionregulating activities of the endogenously encoded Slug and Snail 
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EMT-TFs, and provide indications that normal stem cells and TICs of the same tissue-of-origin could arise from different cellular compartments and exploit different molecular signalling circuits to activate related but distinct signalling pathways. We have previously correlated high levels of SLUG expression with poor prognosis in human breast cancer patients, and attributed such correlation to the experimentally observed EMT-inducing function of SLUG 8 . However, on the basis of the present work, we propose that the prognostic power of SLUG expression may be due in large part to its strong association with basal differentiation, which is, on its own, a well-known feature of aggressive breast cancers 16 . Nonetheless, since our in vivo analyses focused on MMTV promoter-driven tumours, which appear to derive primarily from luminal MECs, we suggest that the functions of Slug in basal MEC-derived tumours remain to be further characterized.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper.
METHODS
Animals. The Slug YFP and Snail YFP alleles were generated by homologous recombination in mouse embryonic stem (ES) cells using standard gene-targeting methods. The MMTV-Neu animals and CAG-mRFP animals were obtained from the Jackson Laboratory (stock numbers 005038 and 005884). The MMTV-PyMT animals were originally obtained from the Jackson Laboratory (stock number 002374) and backcrossed for five generations to C57BL/6 background. Mice were housed and handled in accordance with protocols approved by the Animal Care and Use Committees of the Massachusetts Institute of Technology. Animals were randomized by age and weight. The investigators were blinded to allocation during experiments and outcome assessment for experiments shown in Fig. 3f, g and Extended Data Fig. 10b . Genotyping. PCR primers (59 to 39) for Slug YFP genotyping were (sense strand, AACCTTCTCCAGAATGTCGCTTCTG; antisense strand, TGCAGGTGTATC TTATACACGTGGC) and for Snail YFP genotyping were (sense strand, CTCCCG CATGTCCTTGCTCCACAAG; antisense strand, same as for Slug YFP ). DNA extractions and subsequent PCR reactions were performed using the REDExtract-N-Amp Tissue PCR kit (Sigma XNAT). PCR was performed with 35 cycles of denaturation at 94 uC for 30 s, annealing at 60 uC for 30 s, and elongation at 72 uC for 30 s. Tumour categorization. MMTV-PyMT tumours were categorized into hyperplastic lesions, adenocarcinomas and high-grade carcinomas following the histological criteria described by Lin et al. 12 . Briefly, in the genetic background of our animals, hyperplasic lesions usually occur at about 8-10 weeks of age, and consist of regionally packed lobules formed on the duct. We collectively refer to the adenoma/MIN and early carcinoma stages defined by Lin et al. 12 as adenocarcinomas, as the tumours from 2.5 to 4-month-old animals often have mixed characteristics of both kinds. High-grade carcinoma corresponds to the late carcinoma/advanced invasive carcinoma as defined by Lin et al. 12 , and is always associated with metastatic disease. Immunofluorescence staining. Tumours were fixed in 10% neutral buffered formalin overnight and embedded in paraffin for sectioning. Sections were cut at 5 mm. Tumour sections were deparaffinized in Histoclear II, and antigen retrieval was performed with Nuclear Decloaker (Biocare Medical) using a microwave. Sections were then blocked with 0.5% normal donkey serum (Jackson ImmunoResearch Laboratories) in PBST (PBS 1 0.3% Triton X-100) for 1 h at room temperature. Sections were incubated with primary antibody at 4 uC overnight. After three washes with PBS, sections were incubated with secondary antibodies (Biotium) and DAPI for 2 h at room temperature, washed three times with PBS, and mounted in Prolong gold antifade reagent (Invitrogen P36930). For anti-Slug, anti-Snail and anti-Zeb1 immunofluorescence, the signals were amplified with the TSA Plus Systems (Perkin Elmer) following manufacturer's instructions.
Tumour organoids were fixed in collagen I gel with 4% paraformaldehyde for 1 h at room temperature, blocked with 0.5% normal donkey serum in PBST, and then incubated with primary antibodies at 4 uC overnight. After five washes with PBST, organoids were incubated with DAPI, secondary antibodies and Phalloidin at 4 uC overnight. After five washes with PBST, the collagen I gel containing the organoids were mounted in Prolong gold antifade reagent.
Cultured tumour cells were fixed in 4% paraformaldehyde and blocked with 0.1% normal donkey serum in PBST for half an hour at room temperature. Cells were incubated in specific primary antibodies for 1-2 h, washed three times with PBS, then incubated with secondary antibodies for 1 h at room temperature. After three washes with PBS, stained cells were mounted in Prolong gold antifade reagent.
Immunostained samples were imaged using Zeiss LSM710 and Zeiss LSM700 confocal microscopes and analysed with Zen software.
Antibodies used in this study are listed in the Supplementary Information. Tumour dissociation, FACS fractionation and derivation of tumour cell lines. Tumours were taken from the animals aseptically. At least one fragment from each tumour was saved for histological staging of the tumour. The remainder of each tumour was then minced with a razor blade, and the minced chunks were then rinsed three times with PBS, and digested with collagenase A followed by trypLEselect (Invitrogen). The dissociated tumour cells were then washed twice with DMEM with 10% FBS, and filtered through a 70 mm and 40 mm cell strainer. The resulting cells were stained with DAPI, anti-EpCAM antibody, washed three times with PBS, and resuspended in PBS for flow cytometry analysis and FACS fractionation.
To establish tumour cell lines, 1 3 10 7 dissociated and filtered tumour cells were plated in a 10 cm dish in DMEM/F12 supplemented with 5% adult bovine serum, non-essential amino acids (Invitrogen), and penicillin/streptomycin. On the next day, dead cells were removed by medium change, and the attached cells were passaged at 1:2 to 1:3 for about five passages until each culture was established.
Tumour cell lines were all derived from high-grade carcinomas of 6-7 months old females. Cell lines and cell culture. PyMT tumour cell lines were cultured in DMEM/F12 (1:1) supplemented with 5% adult bovine serum (Sigma B9433), non-essential amino acid (Invitrogen 11140), and Pen/Strep (Invitrogen 15070). MDA-MB-231, MDA-MB-361 and MDA-MB-468 cells were culture in DMEM/F12 (1:1) supplemented with 10% inactivated fetal bovine serum (Sigma F4135) and Pen/ Strep. SKBR3, BT20 and MCF7Ras cells were cultured in DMEM supplemented with 10% inactivated fetal bovine serum and Pen/Strep. SUM149 and SUM159 cells were cultured in F12 media supplemented with 5% inactivated fetal bovine serum, insulin (5 mg ml 21 ), and hydrocortisone (1 mg ml 21 ). T47D, HS578T and BT549 cells were cultured in RPMI supplemented with 10% inactivated fetal bovine serum and Pen/Strep. MCF10A cells were cultured in DMEM/F12 supplemented with 5% horse serum (Sigma H1207), insulin (10 mg ml 21 Sigma I9278), EGF (100 mg ml 21 Sigma E9644), hydrocortizone (0.5 mg ml 21 Sigma H0888), and cholera toxin (100 ng ml 21 Sigma C8052). All human breast cancer cell lines were obtained from ATCC, and are free of mycoplasma contamination.
MMTV-PyMT tumour organoids culture was performed as previously described 13 . 3D organoid culture of primary MECs was performed as previously described 8 . Tumour-sphere assays were performed as described in Tam et al. 31 . 200 cells (1,000 cells for MDA-MB-361 cells) were plated into each well of 96-well ultra-low attachment plate to score tumour-sphere formation efficiency. Five wells were analysed for each condition. Tumour cell implantation. For cleared mammary fat pad transplantation, primary MECs were isolated from the mammary glands of 4-to 5-week-old virgin female mice by collagenase and trypsin digestion. Sorted EpCAM 1 cells were suspended in 10 ml PBS containing 50% Matrigel, and injected into the inguinal mammary fat pads of 3-week-old NOD/SCID mice, whose endogenous mammary epithelium were cleared at the time of the injection. For tail-vein injection, tumour cells were resuspended in 100 ml PBS, and injected into male animals. The lungs were examined 4-8 weeks post injection. For subcutaneous injections, tumour cells were suspended in 100 ml PBS with or without Matrigel (as indicated in the figures) into the flanks of male animals. The tumour incidence and weight were measured 2-3 months post injection. For orthotopic tumour transplantations, tumour cells were resuspended in 20 ml media with the indicated amount of Matrigel and injected into mammary fat pads. Host animals were randomized by weight. In Fig. 4c , 10 5 PyMT tumour cells were injected unilaterally into the mammary fat pad (without matrigel) to score primary tumour burden and metastatic dissemination (six animals for each group). In Fig. 4d , 10 6 MDA-MB-231 cells were injected bilaterally (with 20% matrigel) to score primary tumour burden and metastatic dissemination (five animals for each group). For the metastasis quantification, the lungs were examined under a Leica fluorescence dissecting microscope. Blinded quantifications were performed when scoring the numbers of lung metastases. For limiting dilution analyses, the frequency of TICs in the cell population being transplanted was calculated using the Extreme Limiting Dilution Analysis Program (http://bioinf.wehi.edu.au/software/elda/index.html) 32 . Cleared mammary fat pad injection. Cleared mammary fat pad injections were performed as previously described 8 . Briefly, 1 3 10 5 cells were suspended in 10 ml PBS containing 50% Matrigel and injected into the inguinal mammary fat pads of NOD/SCID female mice that had previously been cleared of endogenous mammary epithelium. Gland reconstitutions were assessed under fluorescence dissecting microscope at 3 months post injection. RNA isolation, reverse transcription and qPCR analysis. Total RNA from freshly sorted primary tumour cells was extracted using Trizol (Invitrogen), and column-purified with PicoPure RNA Isolation Kit (Applied Biosystems). cDNA synthesis was performed with 0.2-2 mg of total RNA using SuperScript III First-Strand Synthesis System (Invitrogen). mRNA levels were measured with genespecific primers using the Roche LightCycler 480 system (Roche). Relative expression levels were normalized to b-actin. Primers used for qPCR analysis are listed in Supplementary Information. shRNA vectors. The sources or targeting sequences of the shRNA used in the study are as follows: mouse shSlug, shSlug4 from Guo et al. 8 Meta-analysis of oncogenomic data. To test whether the expression of Slug or Snail correlated with distant metastasis-free survival (all subtypes, n 5 1,610) and relapse-free survival (ER 1 patients, n 5 1,802; PR 1 patients, n 5 525; ER 2 PR 2 patients, n 5 346) the data sets GSE1456, GSE2034, GSE2990, GSE3494, GSE4922, GSE6532, GSE7390, GSE11121, GSE12093, GSE5327, GSE9195, GSE16391, GSE12276, GSE2603, GSE17705, GSE21653, GSE16446, GSE17907, GSE19615, GSE20685, GSE20711, GSE26971, GSE31448, GSE31519, E-MTAB-365, GSE20194 and GSE20271 were analysed and Kaplan-Meier plots were generated LETTER RESEARCH using http://kmplot.com (ref. 24 ). The patient samples were grouped as either high or low expressor for the genes of interest based on the expression level of the selected gene, and the upper tertile were used as the cut-off and median is computed over the entire data set. Chromatin immunoprecipitation sequencing. ChIP assay was carried out as described previously 31 . The ChIP-seq results have been deposited to Gene Expression Omnibus (GEO) under accession number GSE61198. We performed ChIP-seq experiments using either an anti-Slug or anti-Snail antibody. In the Slughigh pBl.1G cells, as anticipated, we could only recover chromatin fragments from Slug ChIP but not Snail ChIP. Conversely, from the Snail high pBl.3G cells, chromatin fragments were only recoverable from Snail ChIP but not Slug ChIP, demonstrating the specificities of these antibodies. Slug-or Snail-bound DNA sites were determined with Model-based Analysis of ChIP-Seq (MACS) algorithm, and bound target genes were defined as containing Slug or Snail occupancy within 5 kb upstream and downstream relative to the transcription start site for each RefSeq transcript 35 . Fold enrichment of each MACS peak was calculated against the whole-cell extract. Enriched motifs were identified using 1,000 nucleotides centred at the peak summit of the top 1,000 Slug and Snail peaks (ranked by MACS peak scores). The sequences were processed through MemeChIP (http://meme.nbcr.net/meme/cgi-bin/meme-chip.cgi) using default settings.
Gene set enrichment analyses (GSEA) were performed with the GSEA platform of the Broad Institute (http://www.broadinstitute.org/gsea/index.jsp). Slug-bound genes and Snail-bound genes were ranked according to the fold enrichment of the correspondent MACS peaks.
For SLUG and SNAIL ChIP-qPCR in MDA-MB-231 cells, ChIP-enriched DNA was analysed by real-time PCR using the ABI PRISM 7900 sequence detection system and SYBR green master mix. Relative occupancy values were calculated by determining the apparent immunoprecipitation efficiency (ratios of the amount of immunoprecipitated DNA to that of the input sample) and normalized to the level observed. The primers used for the real-time PCR are ZEB1 target locus forward ACAAGCGAGAGGATCATGGCG, reverse CACTCACCGTTATTGCGCCG; ZEB1 control locus forward TAATAATGGGCGGCAACGGC, reverse AGGAA CCAAAGCGAGCCCCT. Statistical analysis. Statistical analyses were carried out by two-tailed Student's t-test unless otherwise specified. No statistical methods were used to predetermine sample size. Fig. 3g were isolated from (left panel) and H&E staining of primary tumours formed by the indicated populations following subcutaneous implantation (with 25% Matrigel). Scale bar, 200 mm. f, Primary tumour burdens formed by the indicated populations after subcutaneous implantation (for EpCAM low Slug low cells 1 3 10 4 cells were injected, for the other two groups 1 3 10 5 cells were injected). Primary tumours and lungs were analysed 10 weeks post injection (n 5 10 sites of injection for each group). Open circle indicates failure of tumour initiation. Source Data is associated with this figure. g, H&E staining of lung sections showing metastatic outgrowths spawned by the indicated cell populations following subcutaneous implantation. Scale bar, 500 mm. 
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